INSM Return on Tangible Equity | INSMED INC

INSMED INC (INSM) Return on Tangible Equity

2026-06-30: Return Tang Equity -165.81%.
2026-03-31: Return Tang Equity -250.17%.
2025-12-31: Return Tang Equity -252.72%.
2025-09-30: Return Tang Equity -163.32%.

Complete source-backed return tang equity history.

Available history: 2009-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-165.81%
2026-03-31	-250.17%
2025-12-31	-252.72%
2025-09-30	-163.32%
2025-06-30	-97.81%
2025-03-31	1074.06%
2024-12-31	-1008.39%
2024-09-30	-300.74%
2024-06-30	506.53%
2024-03-31	112.59%
2023-12-31	140.97%
2023-09-30	147.55%
2023-06-30	194.32%
2023-03-31	220.21%
2022-12-31	411.87%
2022-09-30	183.99%
2022-06-30	254.95%
2022-03-31	492.96%
2021-12-31	-216.73%
2021-09-30	-144.35%
2021-06-30	-77.39%
2021-03-31	-207.87%
2020-12-31	-129.77%
2020-09-30	-79.73%
2020-06-30	-68.30%
2020-03-31	-159.82%
2019-12-31	-122.28%
2019-09-30	-117.59%
2019-06-30	-106.52%
2019-03-31	-380.47%
2018-12-31	-216.78%
2018-09-30	-128.78%
2018-06-30	-81.78%
2018-03-31	-59.41%
2017-12-31	-63.61%
2017-09-30	-46.44%
2017-06-30	-225.60%
2017-03-31	-148.05%
2016-12-31	-114.11%
2016-09-30	-63.86%
2016-06-30	-52.81%
2016-03-31	-44.02%
2015-12-31	-37.92%
2015-09-30	-30.85%
2015-06-30	-26.72%
2015-03-31	-55.94%
2014-12-31	-42.50%
2014-09-30	-38.62%
2014-06-30	-55.90%
2014-03-31	-37.06%
2012-12-31	-34.23%
2012-09-30	-24.95%
2012-06-30	-49.53%
2012-03-31	-46.53%
2011-12-31	-44.44%
2011-09-30	-40.29%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-252.72%
2024-12-31	-1008.39%
2023-12-31	140.97%
2022-12-31	411.87%
2021-12-31	-216.73%
2020-12-31	-129.77%
2019-12-31	-122.28%
2018-12-31	-216.78%
2017-12-31	-63.61%
2016-12-31	-114.11%
2015-12-31	-37.92%
2014-12-31	-42.50%
2013-12-31	-39.12%
2012-12-31	-34.23%
2011-12-31	-44.44%
2010-12-31	-3.45%
2009-12-31	95.51%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Roivant Sciences Ltd. (ROIV)		$26.105B	-96.08
Zoetis Inc. (ZTS)	United States	$29.045B	11.38
Royalty Pharma plc (RPRX)	United States	$22.628B
UNITED THERAPEUTICS Corp (UTHR)	United States	$20.249B	17.64
Viatris Inc (VTRS)	United States	$20.008B	-0.00
ALNYLAM PHARMACEUTICALS, INC. (ALNY)	United States	$33.420B	54.94
Jazz Pharmaceuticals plc (JAZZ)		$15.333B	16.07
Summit Therapeutics Inc. (SMMT)	United States	$13.071B	-13.21
BridgeBio Pharma, Inc. (BBIO)	United States	$12.947B	-20.72
CORCEPT THERAPEUTICS INC (CORT)	United States	$12.804B	169.10